Evaluation of sNfL as a Biomarker for Paclitaxel-Induced Peripheral Neurotoxicity Through an Integrated PKPD Model.
Saved in:
| Title: | Evaluation of sNfL as a Biomarker for Paclitaxel-Induced Peripheral Neurotoxicity Through an Integrated PKPD Model. |
|---|---|
| Authors: | Ibrahim EIK; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Girdenyté M; Department of Pharmacy, Uppsala University, Uppsala, Sweden.; Pharmacy and Pharmacology Center, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Hu Y; Department of Pharmacy, Uppsala University, Uppsala, Sweden.; Non-Clinical Safety & DMPK, BioNTech SE, Mainz, Germany., Di Cesare Mannelli L; Department of Neuroscience, Psychology, Drug Research and Child Health - Neurofarba - Section of Pharmacology and Toxicology, University of Florence, Florence, Italy., Balayssac D; Direction de La Recherche Clinique Et de L'Innovation, Université Clermont Auvergne, INSERM, NEURO-DOL, CHU Clermont-Ferrand, Clermont-Ferrand, U1107, France., Busserolles J; Université Clermont Auvergne, INSERM, NEURO-DOL, Clermont-Ferrand, U1107, France., Theil D; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Roche Pharmaceutical Research and Early Development , Roche Innovation Center, Basel, Switzerland., Roussignol G; Preclinical Safety, Sanofi, R&D, Montpellier, France., Perrault O; Preclinical Safety, Sanofi, R&D, Montpellier, France., Le Berre N; Preclinical Safety, Sanofi, R&D, Montpellier, France., Chanut F; Preclinical Safety, Sanofi, R&D, Chilly Mazarin & Vitry, France., Slaoui M; Preclinical Safety, Sanofi, R&D, Vitry, France., Loryan I; Department of Pharmacy, Uppsala University, Uppsala, Sweden. irena.loryan@uu.se., Friberg LE; Department of Pharmacy, Uppsala University, Uppsala, Sweden. lena.friberg@uu.se. |
| Source: | Pharmaceutical research [Pharm Res] 2026 Apr; Vol. 43 (4), pp. 1071-1088. Date of Electronic Publication: 2026 Mar 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-904X (Electronic) Linking ISSN: 07248741 NLM ISO Abbreviation: Pharm Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41826588 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evaluation of sNfL as a Biomarker for Paclitaxel-Induced Peripheral Neurotoxicity Through an Integrated PKPD Model. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ibrahim+EIK%22">Ibrahim EIK</searchLink>; Department of Pharmacy, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Girdenyté+M%22">Girdenyté M</searchLink>; Department of Pharmacy, Uppsala University, Uppsala, Sweden.; Pharmacy and Pharmacology Center, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.<br /><searchLink fieldCode="AU" term="%22Hu+Y%22">Hu Y</searchLink>; Department of Pharmacy, Uppsala University, Uppsala, Sweden.; Non-Clinical Safety & DMPK, BioNTech SE, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Di+Cesare+Mannelli+L%22">Di Cesare Mannelli L</searchLink>; Department of Neuroscience, Psychology, Drug Research and Child Health - Neurofarba - Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Balayssac+D%22">Balayssac D</searchLink>; Direction de La Recherche Clinique Et de L'Innovation, Université Clermont Auvergne, INSERM, NEURO-DOL, CHU Clermont-Ferrand, Clermont-Ferrand, U1107, France.<br /><searchLink fieldCode="AU" term="%22Busserolles+J%22">Busserolles J</searchLink>; Université Clermont Auvergne, INSERM, NEURO-DOL, Clermont-Ferrand, U1107, France.<br /><searchLink fieldCode="AU" term="%22Theil+D%22">Theil D</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Roche Pharmaceutical Research and Early Development , Roche Innovation Center, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Roussignol+G%22">Roussignol G</searchLink>; Preclinical Safety, Sanofi, R&D, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Perrault+O%22">Perrault O</searchLink>; Preclinical Safety, Sanofi, R&D, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Le+Berre+N%22">Le Berre N</searchLink>; Preclinical Safety, Sanofi, R&D, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Chanut+F%22">Chanut F</searchLink>; Preclinical Safety, Sanofi, R&D, Chilly Mazarin & Vitry, France.<br /><searchLink fieldCode="AU" term="%22Slaoui+M%22">Slaoui M</searchLink>; Preclinical Safety, Sanofi, R&D, Vitry, France.<br /><searchLink fieldCode="AU" term="%22Loryan+I%22">Loryan I</searchLink>; Department of Pharmacy, Uppsala University, Uppsala, Sweden. irena.loryan@uu.se.<br /><searchLink fieldCode="AU" term="%22Friberg+LE%22">Friberg LE</searchLink>; Department of Pharmacy, Uppsala University, Uppsala, Sweden. lena.friberg@uu.se. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406521%22">Pharmaceutical research</searchLink> [Pharm Res] 2026 Apr; Vol. 43 (4), pp. 1071-1088. <i>Date of Electronic Publication: </i>2026 Mar 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%2FPlenum+Publishers%22">Kluwer Academic/Plenum Publishers </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8406521 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-904X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207248741%22">07248741 </searchLink><i>NLM ISO Abbreviation: </i>Pharm Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41826588 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11095-026-04053-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1071 Titles: – TitleFull: Evaluation of sNfL as a Biomarker for Paclitaxel-Induced Peripheral Neurotoxicity Through an Integrated PKPD Model. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ibrahim EIK – PersonEntity: Name: NameFull: Girdenyté M – PersonEntity: Name: NameFull: Hu Y – PersonEntity: Name: NameFull: Di Cesare Mannelli L – PersonEntity: Name: NameFull: Balayssac D – PersonEntity: Name: NameFull: Busserolles J – PersonEntity: Name: NameFull: Theil D – PersonEntity: Name: NameFull: Roussignol G – PersonEntity: Name: NameFull: Perrault O – PersonEntity: Name: NameFull: Le Berre N – PersonEntity: Name: NameFull: Chanut F – PersonEntity: Name: NameFull: Slaoui M – PersonEntity: Name: NameFull: Loryan I – PersonEntity: Name: NameFull: Friberg LE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1573-904X Numbering: – Type: volume Value: 43 – Type: issue Value: 4 Titles: – TitleFull: Pharmaceutical research Type: main |
| ResultId | 1 |